ZA898553B - The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c - Google Patents

The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c

Info

Publication number: ZA898553B
Authority: ZA; South Africa
Prior art keywords: protein kinase; calmodulin; inhibitor; calcium; ethylenediaminetetraacetic acid
Prior art date: 1988-11-10

Application number

ZA898553A

Inventor

Ferdinand Hucho

Hucho Ferdinand

Iris Pribilla

Pribilla Iris

Werner Schiebler

Schiebler Werner

Dominique Tripier

Tripier Dominique

Herbert Kogler

Kogler Herbert

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-10

Filing date

1989-11-09

Publication date

1990-08-29

1989-11-09 Application filed by Hoechst Ag filed Critical Hoechst Ag

1990-08-29 Publication of ZA898553B publication Critical patent/ZA898553B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Virology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)

ZA898553A 1988-11-10 1989-11-09 The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c ZA898553B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3838068		1988-11-10

Publications (1)

Publication Number	Publication Date
ZA898553B true ZA898553B (en)	1990-08-29

Family

ID=6366838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA898553A ZA898553B (en)	1988-11-10	1989-11-09	The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c

Country Status (11)

Country	Link
EP (1)	EP0368223A3 (en)
JP (1)	JPH02180818A (en)
KR (1)	KR900007410A (en)
CN (1)	CN1042545A (en)
AU (1)	AU617892B2 (en)
CA (1)	CA2002637A1 (en)
DE (1)	DE3937015A1 (en)
DK (1)	DK560989A (en)
HU (1)	HU204195B (en)
PT (1)	PT92281A (en)
ZA (1)	ZA898553B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4112103C2 (en) *	1991-02-18	1994-07-14	Matthias Mueller	Use of acetic acid to regulate blood sugar levels
AU4205597A (en) *	1996-08-20	1998-03-06	Novartis Ag	Methods for prevention of cellular proliferation and restenosis
GB9727224D0 (en) *	1997-12-23	1998-02-25	Nycomed Imaging As	Method
DE10138912A1 (en) *	2001-08-08	2003-02-27	Medinnova Ges Med Innovationen	Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances
HU229104B1 (en)	2007-11-22	2013-07-29	Pharmateka Bt	Use of edta and its salts for the prevention and treatment of bacterial intestinal swine diseases caused by brachyspira hyodysenteriae and for enhancement of efficiency of antibiotics in curing such illnesses
EE05628B1 (en)	2010-12-23	2013-02-15	Tallinna Tehnikaülikool	Composite polymeric material with mineral fillers
CN111450085A (en) *	2020-05-22	2020-07-28	颜廷良	Broad-spectrum anti-tumor medicine and preparation method and application thereof

1989
- 1989-11-07 DE DE3937015A patent/DE3937015A1/en not_active Withdrawn
- 1989-11-07 EP EP19890120550 patent/EP0368223A3/en not_active Withdrawn
- 1989-11-08 KR KR1019890016138A patent/KR900007410A/en not_active Application Discontinuation
- 1989-11-09 DK DK560989A patent/DK560989A/en not_active Application Discontinuation
- 1989-11-09 JP JP1290165A patent/JPH02180818A/en active Pending
- 1989-11-09 ZA ZA898553A patent/ZA898553B/en unknown
- 1989-11-09 CN CN89108456A patent/CN1042545A/en active Pending
- 1989-11-09 CA CA002002637A patent/CA2002637A1/en not_active Abandoned
- 1989-11-09 AU AU44504/89A patent/AU617892B2/en not_active Ceased
- 1989-11-10 PT PT92281A patent/PT92281A/en not_active Application Discontinuation
- 1989-11-10 HU HU895861A patent/HU204195B/en unknown

Also Published As

Publication number	Publication date
KR900007410A (en)	1990-06-01
AU617892B2 (en)	1991-12-05
DK560989D0 (en)	1989-11-09
AU4450489A (en)	1990-05-17
JPH02180818A (en)	1990-07-13
PT92281A (en)	1990-05-31
HU204195B (en)	1991-12-30
HUT51893A (en)	1990-06-28
EP0368223A2 (en)	1990-05-16
CA2002637A1 (en)	1990-05-10
EP0368223A3 (en)	1991-09-25
CN1042545A (en)	1990-05-30
DE3937015A1 (en)	1990-05-17
DK560989A (en)	1990-05-11
HU895861D0 (en)	1990-02-28

Similar Documents

Publication	Publication Date	Title
PH30794A (en)	1997-10-17	Inhibition of phosphatidylinositol 3-kinase with worthmannin and analogs thereof.
PH25726A (en)	1991-10-18	Substituted guanidines
EG18081A (en)	1991-08-30	Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as the use indurugs
NO882200D0 (en)	1988-05-20	PROCEDURE FOR THE PREPARATION OF CALCIUM SULPHATE-ALFA HALIBRATE.
SG53193G (en)	1993-06-25	Deodorizer for refrigerators of the like
ZA931935B (en)	1993-12-30	Preparation of substituted guanidines
ZA885371B (en)	1989-04-26	Tissue factor inhibitor
HU893412D0 (en)	1991-05-28	Inhibitors of interleucin-1
NO881215D0 (en)	1988-03-18	PROCEDURE FOR THE PREPARATION OF ALGES WITH IMPROVED BIOLOGICAL EFFECTS.
ZA898553B (en)	1990-08-29	The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
GB2251402B (en)	1993-06-23	Procedure for the manufacture of contour-stable objects
NO893326L (en)	1990-02-20	PROCEDURE FOR THE NEUTRALIZATION OF SULVIC ACID CONTAINING ZINCIONS.
GB8717932D0 (en)	1987-09-03	Inhibitor of protein synthesis
IT8822524A0 (en)	1988-11-04	PROCEDURE FOR THE PREPARATION OF 6-OXOPENICILLANATES
EP0411395A3 (en)	1991-11-13	Use of ace inhibitors for atherosclerosis-prophylaxis
ZA887764B (en)	1989-06-28	Potentiation of antihypertensive effect of ace inhibitors
GB8700950D0 (en)	1987-02-18	Treatment of super-alloy surfaces
ATA251487A (en)	1993-03-15	WINIFIFIERS FOR SIGHTING GOODS OF THE FINEST GRIT
GB8619830D0 (en)	1986-09-24	Inhibitor of protein synthesis
ZA893318B (en)	1989-12-27	Agents for enhancing the growth of livestock
IE871889L (en)	1988-01-15	Inhibitor of protein synthesis
NO880034D0 (en)	1988-01-06	PROCEDURE FOR THE PREPARATION OF CRYSTALLINIC AMINO PROTECTED BETA-BENZYL-L-ASPARTIC ACID.
CS521587A1 (en)	1988-08-16	Stabilizing agent for the determination of catalitic concentration of alaninaminotransferase
LT2320B (en)	1993-12-15	FERTILIZER FOR DETERMINATION OF LACTOSE
NO914588L (en)	1991-11-22	ENZYMM CATALYzed PROCEDURE FOR THE PREPARATION OF N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMAMIDS